3627 results for «303»
3627 results
EuroPCR 2021 Hotlines / Late-Breaking Trials in bifurcation lesions: EBC MAIN and more!
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in bifurcation lesions:
- EBC MAIN - the European Bifurcation Club Left Main Coronary Bifurcation Study
- Clinical Outcomes after Physiology-Guided Treatment of Coronary Bifurcations
MagicTouch sirolimus coated balloon continues to be the choice of treatment for CAD
19 May 2021 – From EuroPCR 2021
Watch this session presented by Antonio Colombo, Aloke Finn, Sandeep Basavarajaiah, Gianluca Caiazzo and Bernardo Cortese in order to know where to use a DCB in today's clinical practice, to learn about real-world case-based experience and interesting data presentation from various registries and clinical studies, and to understand the technology...
Advancing solutions for tricuspid regurgitation patients: introducing TriClip G4
19 May 2021 – From EuroPCR 2021
Watch this session presented by Francesco Maisano, Philipp Lurz, Fabien Praz, Patrizio Lancellotti and Georg Nickenig in order to learn about patient diagnosis and selection for tricuspid transcatheter treatment with TriClip, about latest clinical data supporting TriClip therapy, and about real life experience and attest product innovation: TriClip G4.
New horizons in tricuspid therapy, the TricValve solution
19 May 2021 – From EuroPCR 2021
Watch this session presented by Michael Haude, Christoph Naber, Mohamed Abdel-Wahab, Mohd Ghazi Azmee, Yahaya Shaiful Azmi, Katharina Kiss and Ignacio Amat Santos in order to learn about the TricValve system's approach to tricuspid regurgitation and right heart disease, to understand how this new generation of tricuspid valve system may...
EuroPCR 2021 Hotlines / Late-Breaking Trials in ACS: COOL AMI EU pivotal rial and more!
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in ACS:
- COOL AMI EU pivotal trial
- Complete versus incomplete revascularization in NSTEMI patients
- Non-hyperaemic IMRangio and long-term clinical outcome in STEMI
PCI in a patient with prior TAVI - Session with LIVE demonstration
18 May 2021 – From EuroPCR 2021
Watch this session if you want to discuss the available data for treating coronary artery disease in patients undergoing TAVI and to understand the role of FFR/IFR in coronary artery disease assessment prior to TAVI.
This session was originally presented during EuroPCR 2021.
Percutaneous mitral treatment: repair - Session with LIVE demonstration
18 May 2021 – From EuroPCR 2021
Watch this session if you want to understand patient selection for percutaneous mitral treatment, to select percutaneous valve repair or replacement and to learn tips and tricks in percutaneous valve treatment.
This session was originally presented during EuroPCR 2021.
How does Paradise renal denervation fit into hypertension treatment management?
20 May 2021 – From EuroPCR 2021
Watch this session presented by Felix Mahfoud, Philipp Lurz, Konstantinos Tsioufis and Joachim Weil in order to understand the ultrasound-based renal denervation procedure and summary of the latest clinical data, to review consensus statements and guidelines for the renal denervation therapy today, and to hear expert perspectives on how to establish...
Percutaneous mitral treatment: replacement
18 May 2021 – From EuroPCR 2021
Watch this session if you want to understand patient selection for percutaneous mitral treatment, to select percutaneous valve repair or replacement, and to learn tips and tricks in percutaneous valve treatment.
This session was originally presented during EuroPCR 2021.
EuroPCR 2021: Opening Ceremony - Education & Innovation in Interventional Cardiovascular Medicine
18 May 2021 – From EuroPCR 2021
Did you miss the livestream of EuroPCR 2021’s official Opening Ceremony? Look back to watch the PCR Chairman William Wijns and PCR Vice-Chairman Jean Fajadet launch this innovative edition of the Course. More than ever it was the right place to be!
Paclitaxel and sirolimus coated balloons: create evidence before claims
20 May 2021 – From EuroPCR 2021
Watch this session presented by Mohd Ali Rosli, Bruno Scheller, Raban Jeger and Sylvia Otto in order to join a controversial discussion about a sirolimus and paclitaxel coated balloon approach, to follow a dedicated discussion on existing evidence on efficacy and safety for paclitaxel and sirolimus coated balloons...
Optimise your TAVI patient's outcomes: implementing the Edwards benchmark programme
20 May 2021 – From EuroPCR 2021
Watch this session presented by Simon Kennon, Olivier Darremont, Helene Eltchaninoff, Derk Frank, Sandra Lauck and Francesco Saia in order to improve access to high quality of care with safe early discharge for selected patients in Europe, to identify strategies to reduce hospital stay and optimise TAVI programmes for...
Shock the Rock: new intravascular lithotripsy real-world data and cases
18 May 2021 – From EuroPCR 2021
Watch this session presented by Emanuele Barbato, Holger Nef, Arif Al Nooryani, Alfonso Ielasi, Michael Haude, Margaret McEntegart and Flavio Luciano Ribichini in order to learn how to optimally adopt Intravascular Lithotripsy (IVL) for treatment of calcified lesions, to identify best practices when using IVL in different clinical settings,...
EuroPCR 2021 Hotlines / Late-Breaking Trials: MAGSTEMI, France ABSORB, FUTURE-II, STRATEGY-IT, AIDA, and PRAGUE 22
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in BRS/BVS:
- Magnesium-based Bioresorbable Scaffold in STEMI: 2 years results
- France Absorb registry: final five years follow-up
- A randomized trial of thinner-strut sirolimus-eluting BRS in de novo lesions
- Three-year follow-up of the prospective bvs stemi strategy-it study
- Final five-year results of AIDA trial
- Bioresorbable...
Empowering DES performance in complex patients to maximise efficacy and safety outcomes
20 May 2021 – From EuroPCR 2021
Watch this session presented by Marco Valgimigli, Istvan Ferenc Edes, Antonio Colombo, Rafael Romaguera, Gennaro Sardella and Pieter Stella in order to identify the key elements and actions to be considered to maximise complex PCI outcomes in diabetes mellitus and high bleeding risks patients, to understand how re-PCI impacts...
EuroPCR 2021 Hotlines / Late-Breaking Trials: POEM, CEL-02, and PENDULUM
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in drugs & devices:
- POEM study: 1-month DAPT after PCI with bioresorbable-polymer EES in HBR patients
- CEL-O2 trial: a novel rapid glycoprotein IIb/IIIa inhibitor(RUC-4) for STEMI patients
- PENDULUM registry study: impact of Clinical Outcomes and Platelet Reactivity After Percutaneous Coronary
EBC Main: Behind the curtain
18 May 2021 – From EuroPCR 2021
Watch this session presented by David Hildick-Smith in order to have additional information about the EBC main trial, to learn about the principal investigator's interpretation of results, and to find out about the European Bifurcation Club's remaining questions to be addressed in future trials.
The new Evolut PRO+ system: optimal procedural outcomes in all patients
20 May 2021 – From EuroPCR 2021
Watch this session presented by Didier Tchetche, Jean Fajadet, Azeem Latib, Anna Sonia Petronio, Daniel Blackman and Tanja Rudolph in order to explore benefits of the new Evolut PRO+ system and its versatility to treat different patient anatomies, to understand how the cusp overlap and commissural alignment techniques can...
Ultra-low contrast 2021: new skills and technologies for next frontier in PCI
18 May 2021 – From EuroPCR 2021
Watch this video presented by Ziad Ali, Nieves Gonzalo, Alexander Becker, Javier Escaned and Billal Patel in order to understand what's the rationale for ULCPCI, to get an overview of techniques that help you dramatically reduce the contrast dose while performing PCI, and to gain some visibility...
Improving personalised vascular care using novel technologies: how can I start?
19 May 2021 – From EuroPCR 2021
Watch this session presented by Salvatore Brugaletta, Nick West, Rasha Al-Lamee, Will Davies, Angela H.E.M. Maas and William Wijns in order to learn more about personalised vascular healthcare, to understand the value of personalised vascular healthcare, and to see practical examples on how this can be implemented in your practice.
